Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03RTC
|
||||
Former ID |
DIB014140
|
||||
Drug Name |
BMS-812204
|
||||
Synonyms |
CB1 antagonists (obesity), BMS; CB1 antagonists (obesity), Bristol-Myers Squibb
|
||||
Indication | Obesity [ICD9: 278; ICD10:E66] | Investigative | [543877] | ||
Company |
Bristol-Myers Squibb Co
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
FC(F)(c1nc(c(Cn2c(=O)c(c3cnc(nc3)C)c(c3n2c(=O)n(n3)CC)c<br />2ccc(cc2)Cl)cc1)C)F
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Antagonist | [543877] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.